Collectively, these data support the concept that ADAM17 inhibition may mitigate the inflammatory–oxidative storm characteristic in ALI, representing a promising, though preliminary, strategy for severe inflammatory liver injury. The gene discussed is ADAM17; the disease is acute respiratory distress syndrome.